health
February 26, 2026
Novartis, Genentech file suit alleging illegal importation of prescription drug
Novartis and Genentech are suing a U.S. company and a Canadian pharmacy over the importation of a Canadian version of their allergy medicine.
TL;DR
- Novartis and Genentech are suing SHARx and a Canadian pharmacy over the importation of Xolair.
- The lawsuit alleges that the importation violates U.S. Food and Drug Administration regulations.
- The companies claim the importation poses risks to patients due to the drug's sensitive storage and handling requirements.
- Alternative funding programs (AFPs) like SHARx are under scrutiny for obtaining overseas drugs at reduced prices.
- Federal authorities have previously stated that importing medications from foreign markets is illegal.
- A similar lawsuit was filed by Gilead Sciences against other AFPs for alleged illegal importation of medications.
Continue reading the original article